A retrospective study evaluating bleeding risk associated with clopidogrel use after percutaneous core biopsy.
Phase of Trial: Phase IV
Latest Information Update: 04 Sep 2017
At a glance
- Drugs Clopidogrel (Primary)
- Indications Cerebrovascular disorders; Coronary artery disease; Myocardial infarction; Peripheral arterial disorders
- Focus Adverse reactions
- 04 Sep 2017 New trial record